Showing results (81-90 of 192) with videos related to
Sort By:
Pageof 20
Vaccines|January 28, 2026
Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" NeoantigensFrancois Xavier Rwandamuriye, Alec J Redwood, Jenette Creaney, et al.Journal of Medical Virology|February 1, 1993
Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virusA H Sherker, J S Twu, G R Reyes, et al.Journal of Virology|February 1, 1980
State of hepatitis B viral DNA in a human hepatoma cell lineP L Marion, F H Salazar, J J Alexander, et al.Cancer Research|October 15, 1994
State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnavirusesM B Rivkina, J M Cullen, W S Robinson, et al.Oncoimmunology|February 21, 2022
What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccinationAlec J Redwood, Ian M Dick, Jenette Creaney, et al.Journal of Virology|December 1, 1979
Polypeptides of hepatitis B virus surface antigen produced by a hepatoma cell lineP L Marion, F H Salazar, J J Alexander, et al.Oncogene|September 22, 2010
Harnessing the immune response to treat cancerH J Steer, R A Lake, A K Nowak, et al.Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigenX S He, H S Chen, K Chu, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1971
DNA in uninfected and virus-infected cells complementary to avian tumor virus RNAP N Rosenthal, H L Robinson, W S Robinson, et al.Plos One|October 25, 2011
Auto-antibodies to β-F1-ATPase and vimentin in malignant mesotheliomaJenette Creaney, Ian M Dick, Deborah Yeoman, et al.Pageof 20